| Valuation method | Value, £ | Upside, % |
|---|---|---|
| Artificial intelligence (AI) | 28.60 | 120 |
| Intrinsic value (DCF) | 6.19 | -52 |
| Graham-Dodd Method | 7.60 | -41 |
| Graham Formula | 6.10 | -53 |
Medios AG, together with its subsidiaries, engages in the wholesale of specialty pharmaceutical drugs in Germany. It operates through Pharmaceutical Supply and Patient-Specific Therapies segments. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies; and patient-specific therapies for dispensing individually dosed tablets. The company was founded in 2016 and is based in Berlin, Germany.